Promising Bone Cancer Therapy Advances To Next Level
... the bone. Diatide Inc., a New Hampshire biotechnology company that has licensedthe technology from BNL, is sponsoring and coordinating the multicenter trial,which will include 100 prostate cancer patients and 75 patients with othercancers. Patients are still being accepted at the participating hospital...Abgenix Reports Positive Survival Data From A Phase II Trial Of ABX-CBL In Graft Versus Host Disease
...ative arrangementswith multiple pharmaceutical and biotechnology companies involving its XenoMousetechnology. In addition, Abgenix has four proprietary antibody productcandidates that are under development internally, two of which are in humanclinical trials. For more information about the company, visit its web ...... Center providesservices to small and medium sized biotechnology and pharmaceutical companies,particularly in the southeast region of Pennsylvania. It specializes in the useof a baculovirus expression vector system (BEVS) and scale-up production ofrecombinant proteins for use in pre-clinical research for diagnost...Turning off cancer shield may allow safer cancer therapy
...ark Biotech, Inc. (QBI), aPleasanton, Calif.-based biotechnology company, reports finding a new drugcalled pifithrin-alpha that in mice protects vulnerable healthy tissues from thedangerous side effects of radiation therapy. Pifithrin works by temporarily blocking the action of a molecule called p53, thegranddaddy...UNC AIDS vaccine researchers awarded $12 million federal grant
...of research atAlphaVax, Inc., a Durham, N.C.-based biotechnology company which holds thecommercial license for the VEE technology from UNC. AlphaVax, the UNC group andscientists from South Africa are working to have a prototype vaccine ready forhuman safety testing by the end of 2000....Researchers discover potential new approach to treating cystic fibrosis
...researchers areworking with the foundation and the biotechnology company Genzyme General, ofCambridge, Mass., to de...tment of rare genetic diseases. A division of the biotechnology companyGenzyme Corporation, Genzyme General has its own common stock (Nasdaq: GENZ)intended to refle...CWRU medical school announces $300 million campaign
... play a central rolein developing Northeast Ohio's biotechnology industry, which will be a majorindustry for the 21st century. Already, several start-up companies have comefrom research breakthroughs that were made at the school, among them Athersys,NeuroControl, Gliatech, and Copernicus," he said. "In add...UT Southwestern scientists develop method of synthesizing antibodies
...tibody substitutes for use in medical diagnostics, biotechnology and biomedical research. Reporting in January's Nature Biotechnology, the investigators explained how they set up a selection system to find peptides that mimic antibodies by binding to specific peptide epitopes, amino-acid compounds that can com......e delivery of small molecules, vaccines and potent biotechnology drugs, and may also serve as a diagnostic tool. (Terry L. Burkoth, Ph.D., PowderJect Pharmaceuticals, Fremont, Calif. MEDI 171, Monday, March 27, 9:50 a.m., Moscone Center, Room 135, Exhibit Level. See page 132 in the final program.) High-tech fa...... and Acorda Therapeutics. Acorda Therapeutics is a biotechnology company that develops therapeutic products for spinal cord injury and other central nervous system conditions. Acorda is planning to complete the preclinical work necessary before human clinical trials can be designed. This work includes scaling up m...First protein 'biochips' may deliver improved detection, diagnosis
...cytogenes, speed is needed, and the combination of biotechnology with computer chips is a possible answer." The biochips would require approval of the Food and Drug Administration before they could be used in food production. Researchers from several schools and disciplines at Purdue played key roles in the develo......bal intellectual property issues for the chemical, biotechnology and pharmaceutical industries; a panel discussion on the opportunities and risks of online preprints for scholarly journals in chemistry; and a salute to the National Science Foundation on its 50th anniversary. Meeting highlights include symposia on...Americans support FDA food biotech policies
...cates most consumers still remain in favor of food biotechnology and the current U.S. Food and Drug Administration ... (59%) consumers still feel they will benefit from biotechnology within the next 5 years. The survey, conducted in May 2000, confirmed that a growing number of consu...Living in the pharmaceutical century
...nto the 21st century, the jobs are coming from the biotechnology and pharmaceutical world. People going into this field need to know its history." The Pharmaceutical Century reports on the effects of technology, drugs and diseases through the decades. Aspirin, for example, changed people's quality of life when it ...Early trial at Thomas Jefferson University Hospital shows Angiostatin is safe
...nction with EntreMed, Inc., a Rockville, Md.-based biotechnology company, have been developing and are now testing anti-angiogenesis drugs in human clinical trials. Dozens of drugs are under development by other companies all over the world. Some researchers believe that Angiostatin and other anti-angiogenesis dr...Natural immune response reduces nerve damage; may lead to improved treatment for spinal cord injury
...udy, funded in part by Proneuron, Ltd., an Israeli biotechnology company, appears in the June 1 issue of The Journal of Neuroscience. Schwartz has an equity position in Proneuron. These studies provide new avenues for development of potential treatments and prevention of paralysis resulting from injury, says Esth...Patent rights stimulate R&D, but fall short in helping poor countries obtain lifesaving drugs
... large research-based pharmaceutical companies and biotechnology firms. However, in a report published this month, world health leaders emphasize that intellectual property protection may not be enough to address the larger problem of how to get cheap drugs to poor countries. The report explores themes discussed......d safe? And who makes that decision? Advances in biotechnology now permit new combinations of genes to be introduced into our foods. These genetically modified (GM) foods have been developed to ensure resistance to diseases in the field, longer shelf life in the store, or better nutritional content. But how do s...